Balchem Corp (BCPC)
155.75
-0.80
(-0.51%)
USD |
NASDAQ |
May 01, 12:14
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 5.080B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | 11.31% |
| Valuation | |
| PE Ratio | 37.35 |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 5.290 |
| Price to Book Value | 4.203 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | 0.87 |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.1572 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 33.89% |
Profile
Edit
| Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries. |
| URL | https://www.balchem.com |
| Investor Relations URL | https://balchem.com/investors/ |
| HQ State/Province | New Jersey |
| Sector | Materials |
| Industry | Chemicals |
| Next Earnings Release | Jul. 25, 2025 (est.) |
| Last Earnings Release | Apr. 24, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Dec. 26, 2024 |
Ratings
Profile
Edit
| Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries. |
| URL | https://www.balchem.com |
| Investor Relations URL | https://balchem.com/investors/ |
| HQ State/Province | New Jersey |
| Sector | Materials |
| Industry | Chemicals |
| Next Earnings Release | Jul. 25, 2025 (est.) |
| Last Earnings Release | Apr. 24, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Dec. 26, 2024 |